StockData
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX) income statement

CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$2.03−0.02 (-0.98%)

Close on Nov 20, 2026Market cap $442.34MP/E –Yield –

See a number that looks wrong?